Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Metamark expands prostate cancer test services to include PROGENSAPCA3 assay

Metamark expands prostate cancer test services to include PROGENSAPCA3 assay

Phase 3 COU-AA-302 results show ZYTIGA plus prednisone prolongs overall survival in men with chemotherapy-naive mCRPC

Phase 3 COU-AA-302 results show ZYTIGA plus prednisone prolongs overall survival in men with chemotherapy-naive mCRPC

Early detection of cancers on the horizon with supersensitive nanodevice

Early detection of cancers on the horizon with supersensitive nanodevice

Access to potentially life-extending cancer drugs varies worldwide

Access to potentially life-extending cancer drugs varies worldwide

ZERO donates mobile health vehicles to Buddhist Tzu Chi Medical Foundation, LSU Health Sciences Center

ZERO donates mobile health vehicles to Buddhist Tzu Chi Medical Foundation, LSU Health Sciences Center

Distinct patterns of gene expression identified in several groups of pancreatic CTCs

Distinct patterns of gene expression identified in several groups of pancreatic CTCs

Researchers test novel robotic system to improve prostate cancer biopsies

Researchers test novel robotic system to improve prostate cancer biopsies

Guidelines recommending routine prostate cancer screening for elderly men have minimal effect

Guidelines recommending routine prostate cancer screening for elderly men have minimal effect

New approach to imaging metastatic tumors

New approach to imaging metastatic tumors

Scientists find 23 new genetic variants that increase risk for prostate cancer

Scientists find 23 new genetic variants that increase risk for prostate cancer

Novel genetic discovery identifies new avenues for prostate cancer treatment

Novel genetic discovery identifies new avenues for prostate cancer treatment

Global study identifies another 23 new prostate cancer risk loci

Global study identifies another 23 new prostate cancer risk loci

Bayer, Orion begin patient enrollment in ODM-201 Phase III trial for castration-resistant prostate cancer

Bayer, Orion begin patient enrollment in ODM-201 Phase III trial for castration-resistant prostate cancer

Assessing genetic variants can help identify men with increased risk of prostate cancer

Assessing genetic variants can help identify men with increased risk of prostate cancer

BGI-VPC Joint Research Laboratory to apply genome research to develop new cancer therapies

BGI-VPC Joint Research Laboratory to apply genome research to develop new cancer therapies

Cancer Research UK, CRT partner with Asterias to trail novel immunotherapy treatment for lung cancer

Cancer Research UK, CRT partner with Asterias to trail novel immunotherapy treatment for lung cancer

American men have worse access to reproductive and sexual health care, shows research

American men have worse access to reproductive and sexual health care, shows research

Experts share tips on prevention of prostate cancer

Experts share tips on prevention of prostate cancer

Low free testosterone predicts prostate cancer reclassification

Low free testosterone predicts prostate cancer reclassification

Endo International introduces topical testosterone gel, FORTESTA Gel

Endo International introduces topical testosterone gel, FORTESTA Gel

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.